NYTimes: Biopharmaceutical Industry Is Banking on Boston

Susan Diesenhouse of The New York Times reports today that Boston may be the new destination for the biopharmaceutical industry. A reported $2.3 billion dollars has been placed into the manufacturing of biopharmaceutical drugs. Diesenhouse reports, that with development costing about $2,400 a square foot for special materials, equipment and equipment testing, decisions to build in Massachusetts, where the cost of living is high, are not made lightly. But biotech companies come here to mine the region’s research and production talent.

Learn more: Biopharmaceutical Industry Is Banking on Boston

Share this article with your social network, just click below to share now!

Share |